{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T12:48:42Z","timestamp":1766407722893,"version":"3.45.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Hemorrhages"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/j.hest.2021.06.001","type":"journal-article","created":{"date-parts":[[2021,6,24]],"date-time":"2021-06-24T06:52:01Z","timestamp":1624517521000},"page":"165-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine"],"prefix":"10.1016","volume":"2","author":[{"given":"Josef","family":"Finsterer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Korn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.hest.2021.06.001_b0005","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/ane.13451","article-title":"SARS-CoV-2 vaccines are not free of neurological side effects","volume":"144","author":"Finsterer","year":"2021","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"10.1016\/j.hest.2021.06.001_b0010","doi-asserted-by":"crossref","first-page":"435","DOI":"10.3390\/vaccines9050435","article-title":"Immune-mediated disease flares or new-onset disease in 27 subjects following mRNA\/DNA SARS-CoV-2 vaccination","volume":"9","author":"Watad","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.hest.2021.06.001_b0015","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2021.279000","article-title":"Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia","author":"Althaus","year":"2021","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.hest.2021.06.001_b0020","doi-asserted-by":"crossref","first-page":"e242220","DOI":"10.1136\/bcr-2021-242220","article-title":"Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination","volume":"14","author":"Fueyo-Rodriguez","year":"2021","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.hest.2021.06.001_b0025","first-page":"141","article-title":"Fatal cerebral haemorrhage after COVID-19 vaccine","volume":"29","author":"Bj\u00f8rnstad-Tuveng","year":"2021","journal-title":"Tidsskr Nor Laegeforen"},{"issue":"22","key":"10.1016\/j.hest.2021.06.001_b0030","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1056\/NEJMoa2104840","article-title":"Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination","volume":"384","author":"Greinacher","year":"2021","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.hest.2021.06.001_b0035","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/HYPERTENSIONAHA.121.17316","article-title":"CHUV COVID vaccination center. Stage III hypertension in patients after mRNA-based SARS-CoV-2 vaccination","volume":"77","author":"Meylan","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.hest.2021.06.001_b0040","doi-asserted-by":"crossref","unstructured":"Leasure AC, Khan YM, Iyer R, et al. Intracerebral hemorrhage in patients with COVID-19: an analysis from the COVID-19 cardiovascular disease registry. Stroke 2021:STROKEAHA121034215.","DOI":"10.1161\/STROKEAHA.121.034215"},{"key":"10.1016\/j.hest.2021.06.001_b0045","doi-asserted-by":"crossref","DOI":"10.12659\/AJCR.931080","article-title":"Thromboelastography-guided anticoagulant therapy for the double hazard of thrombohemorrhagic events in COVID-19: a report of 3 cases","volume":"22","author":"Bunch","year":"2021","journal-title":"Am J Case Rep"},{"issue":"10249","key":"10.1016\/j.hest.2021.06.001_b0050","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0140-6736(20)31604-4","article-title":"Oxford COVID Vaccine Trial Group. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial","volume":"396","author":"Folegatti","year":"2020","journal-title":"Lancet"}],"container-title":["Brain Hemorrhages"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589238X21000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589238X21000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:34:24Z","timestamp":1762886064000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589238X21000292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2589238X21000292"],"URL":"https:\/\/doi.org\/10.1016\/j.hest.2021.06.001","relation":{},"ISSN":["2589-238X"],"issn-type":[{"type":"print","value":"2589-238X"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aphasia seven days after second dose of an mRNA-based SARS-CoV-2 vaccine","name":"articletitle","label":"Article Title"},{"value":"Brain Hemorrhages","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hest.2021.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. This is an open access article under the CC BY-NC-ND license (http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/).","name":"copyright","label":"Copyright"}]}}